MPB,
There are four things that concern me, however. Most of these are not definite problems, just little things.
First, the burn rate.
Second, the company's size and growth rate. Not only has the headcount passed that point where everyone feels that they are personally responsible for the success of the company, but it's increasing at a rate that isn't necessarily conducive to instilling that in new employees. Obviously, this could lead to less productivity/FTE.
Third, with this growth, Millennium is now spread out in at least four different buildings all across Cambridge, which could mean alot of time and money spent shuttling people back and forth.
Fourth, the ever-present uncertainty of patent situation. With the emergence of an EST patent mine field strategy at some genome research centers, there is even greater uncertainty as to whether you own your discoveries.
With these four out there, let me say that other than the fourth, all are a natural consequence of the phenomenal growth at MLNM. What's more, Mark Levin and the rest of management seem more than capable of dealing with these issues. What's more the quality of science at MLNM does not seem to be suffering at all.
biowa |
